It is important to note that the side effect profile can vary considerably depending on the specific bacterial strains, colony-forming unit (CFU) count, and additional ingredients in the formulation
On October 17, 2024, FDA issued a letter to APC and then provided clarification on the FDA website essentially extending enforcement discretion to sterile compounders and that FDA intends to treat compounders consistently at this time. Pharmacy Times : In the legal case challenging the FDA's decision, what are your thoughts on how the FDA may respond, and is there a precedent for this case that may inform a potential decision in this case
If your product shows these signs, its effective concentration has likely decreased regardless of what the label states
Call us at 408.478.3496 and ask about it
Ive rarely seen any of my patients taking Adderall for ADD lose a significant amount of weight, Knopke says
Clinical discretion is paramount